Home
About
Why D4DPR?
Strategic Vision
Platform of Regulations
Leadership
D4DPR Experts
D4DPR Updates
Advocacy
Media
Expert Testimony
Coalition Partners
Education
Cannabis Curriculums
Regulation & Public Health
Harms of Prohibition
Myths, Risks & Uncertainties
Resources
Ask a Question
Regulation
Universal Cannabis Symbol
JOIN
DONATE
Home
Supporting New Jersey's CSA Reclassification of Cannabis
Supporting New Jersey's CSA Reclassification of Cannabis
David L. Nathan, MD, DFAPA
Expert Testimony
|
April 25, 2018
|
Regulatory (cannabis)
Download PDF
</div></div><div class="socialshare blog"><div class="text-block-7"><strong>Share: </strong></div><div class="html-embed-7 w-embed"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A//dfcr.org/post/new-jersey-division-of-consumer-affairs-reclassification-of-marijuana-david-l-nathan-april-2018" target="_blank" class="share-icon-wrap w-inline-block"><img loading="lazy" width="30" src="https://assets-global.website-files.com/6140f19dc034b9b282445f9c/6169a5996d25fba25b1aa18a_facebook.png" alt="" class="social-media-icons"></a></div><div class="html-embed-7 w-embed"><a href="https://twitter.com/intent/tweet?text=https%3A//dfcr.org/post/new-jersey-division-of-consumer-affairs-reclassification-of-marijuana-david-l-nathan-april-2018" target="_blank" class="share-icon-wrap w-inline-block"><img loading="lazy" width="30" src="https://assets-global.website-files.com/6140f19dc034b9b282445f9c/6169a5997f7803a3b9c69bdd_twitter.png" alt="" class="social-media-icons"></a></div><div class="html-embed-7 w-embed"><a class="w-inline-block social-share-btn social-media-icons email" href="mailto:?subject=&body=:%20" target="_blank" title="Email" onclick="window.open('mailto:?subject=' + encodeURIComponent(document.title) + '&body=' + encodeURIComponent('https://dfcr.org/post/new-jersey-division-of-consumer-affairs-reclassification-of-marijuana-david-l-nathan-april-2018')); return false;"><img loading="lazy" width="30" src="https://assets-global.website-files.com/6140f19dc034b9b282445f9c/6194228b96c3d141b17766c4_email-svgrepo-com.svg" alt="" class="social-media-icons"></a></div></div><div class="divider"></div></div><div><h2>About the Author</h2><div class="w-row"><div class="w-col w-col-1"><img alt="David L. Nathan, MD, DFAPA" loading="lazy" width="140" src="https://assets-global.website-files.com/6140f19ec034b96f37445fa8/614cab507994606bc75e09fa_nathan2.jpg" class="image-6"/></div><div class="w-col w-col-11"><h3>David L. Nathan, MD, DFAPA</h3><div class="w-richtext"><p><a href="http://nathanmd.com/" target="_blank"><strong>David L. Nathan, MD, DFAPA</strong></a> is a <a href="https://en.wikipedia.org/wiki/David_L._Nathan" target="_blank">psychiatrist, writer, and educator</a> in Princeton NJ. He is the founder of Doctors for Cannabis Regulation and served as our first President. Dr. Nathan is a Distinguished Fellow of the American Psychiatric Association and Clinical Associate Professor of Psychiatry at Rutgers Robert Wood Johnson Medical School. While maintaining a full-time private practice, he serves as Director of Continuing Medical Education for the Princeton HealthCare System (PHCS) and Director of Professional Education at Princeton House Behavioral Health (PHBH). While serving on the steering committee of New Jersey United For Marijuana Reform (<a href="https://www.njumr.org/" target="_blank">NJUMR.org</a>), Dr. Nathan was surprised by the absence of any national organization to act as the voice of physicians who wish to guide our nation along a well-regulated path to cannabis legalization. This need was the inspiration for Doctors for Cannabis Regulation.</p></div></div></div></div></div></div><div class="footer-section"><div class="content-section footer no-padding"><div class="container-wrapper-second footer"><div class="footer-block"><img src="https://assets-global.website-files.com/6140f19dc034b9b282445f9c/65170f78c8bbb4e95b23593d_D4DPR%20Horizonal%20Light%20Bkgrd.png" loading="lazy" width="286" sizes="(max-width: 479px) 83vw, (max-width: 767px) 41vw, (max-width: 991px) 29vw, (max-width: 1279px) 18vw, (max-width: 1919px) 222.2265625px, 286px" alt="D4DPR logo" srcset="https://assets-global.website-files.com/6140f19dc034b9b282445f9c/65170f78c8bbb4e95b23593d_D4DPR%20Horizonal%20Light%20Bkgrd-p-500.png 500w, https://assets-global.website-files.com/6140f19dc034b9b282445f9c/65170f78c8bbb4e95b23593d_D4DPR%20Horizonal%20Light%20Bkgrd-p-800.png 800w, https://assets-global.website-files.com/6140f19dc034b9b282445f9c/65170f78c8bbb4e95b23593d_D4DPR%20Horizonal%20Light%20Bkgrd-p-1080.png 1080w, https://assets-global.website-files.com/6140f19dc034b9b282445f9c/65170f78c8bbb4e95b23593d_D4DPR%20Horizonal%20Light%20Bkgrd.png 1300w"/><div class="w-embed"><style> .image-container { text-align: center; } </style> <div class="image-container"> <a href="https://www.guidestar.org/profile/shared/ac11f4b2-d8c8-45e0-8006-58a23796b851" target="_blank"> <img src="https://widgets.guidestar.org/TransparencySeal/9511393" width="100" alt="Guidestar Transparency Seal"> </a> </div></div></div><div class="footer-block top"><h4 class="blog-tittle dark footer">Follow</h4><div class="div-block-25 w-clearfix"><a href="https://www.facebook.com/D4DPRorg/" Title="facebook" target="_blank" class="top-social-block second-version w-inline-block w-clearfix"><img src="https://assets-global.website-files.com/6140f19dc034b9b282445f9c/6169a5996d25fba25b1aa18a_facebook.png" width="54" alt="Facebook" class="top-nav-icon"/></a><a href="https://twitter.com/d4dprorg" Title="Twitter" target="_blank" class="top-social-block second-version w-inline-block w-clearfix"><img src="https://assets-global.website-files.com/6140f19dc034b9b282445f9c/6169a5997f7803a3b9c69bdd_twitter.png" width="49" alt="Twitter" class="top-nav-icon"/></a><a href="https://www.linkedin.com/company/d4dprorg/" Title="LinkedIn" target="_blank" class="top-social-block second-version w-inline-block w-clearfix"><img src="https://assets-global.website-files.com/6140f19dc034b9b282445f9c/6169a59a8bfa9732bf790b6e_linkedin.png" width="40" alt="LinkedIn" class="top-nav-icon"/></a><a href="https://www.instagram.com/d4dprorg/" Title="Instagram" target="_blank" class="top-social-block second-version w-inline-block w-clearfix"><img src="https://assets-global.website-files.com/6140f19dc034b9b282445f9c/6169a599335ab4511c5e6dd0_insta.png" width="53" alt="Instagram" class="top-nav-icon"/></a><a href="https://www.youtube.com/channel/UC7GLBo2PRDXuL8dzdQC2A3Q" Title="YouTube" target="_blank" class="top-social-block second-version w-inline-block w-clearfix"><img src="https://assets-global.website-files.com/6140f19dc034b9b282445f9c/6169a708d0c8a4bd4cf361c6_youtube-svgrepo-com%20(1).svg" width="56" alt="YouTube" class="top-nav-icon"/></a></div></div><div class="footer-block contact"><h4 class="blog-tittle dark footer">Contact Us</h4><p><a href="mailto:info@d4dpr.org">info@d4dpr.org</a></p><p>Phone: (202) 930-0097</p><p>Doctors for Drug Policy Reform<br/>712 H Street NE, Suite 1290<br/>Washington, DC 20002</p></div><div class="footer-block third"><h4 class="blog-tittle dark footer">D4DPR News & Events</h4><a href="https://d4dpr.org/updates/media" class="link-block w-inline-block"><div class="text-block-4">Media</div></a><a href="/expert-testimony" class="link-block w-inline-block"><div class="text-block-4">Expert Testimony</div></a><a href="https://d4dpr.org/updates/education" class="link-block w-inline-block"><div class="text-block-4">Education</div></a><a href="https://d4dpr.org/updates/dfcr" class="link-block w-inline-block"><div class="text-block-4">D4DPR Updates</div></a></div><div class="footer-block fourth"><h4 class="blog-tittle dark footer">Sign Up for Our Newsletter!</h4><div class="html-embed-4 w-embed w-iframe"><iframe src="https://d4dpr.dm.networkforgood.com/forms/102955?iframe=1" width="100%" height="380px" frameborder="0">
©2024 Doctors for Cannabis Regulation, LLC DBA Doctors for Drug Policy Reform. All rights reserved.
